Viewing Study NCT00623766


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-05 @ 5:33 PM
Study NCT ID: NCT00623766
Status: COMPLETED
Last Update Posted: 2014-06-09
First Post: 2008-02-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Sponsor: Bristol-Myers Squibb
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-07
Start Date Type: None
Primary Completion Date: 2009-09
Primary Completion Date Type: ACTUAL
Completion Date: 2012-10
Completion Date Type: ACTUAL
First Submit Date: 2008-02-19
First Submit QC Date: None
Study First Post Date: 2008-02-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-12-17
Results First Submit QC Date: None
Results First Post Date: 2014-06-09
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2011-07-20
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-05-27
Last Update Post Date: 2014-06-09
Last Update Post Date Type: ESTIMATED